34 天前 - … (USA and Europe) to fight the initial phase of COVID-19 pandemic, with an emphasis
on passive immunotherapies such as convalescent plasma and anti-Spike monoclonal …

34 天前 - … this study sought to forecast the efficacy of immunotherapy ORR in non-small cell
lung … COVID-19, utilizing the HPExplainPro framework and data collected from 246 COVID-19 …

35 天前 - … An evident and justified instance of these local therapies occurred during the
COVID-19 pandemic, a period when surgical interventions carried out in hospital settings were not …

36 天前 - … Since COVID-19 mutates continuously to overcome the existing vaccines, our
steady efforts are indispensable to clarify the pathophysiology of CARs and contribute to the …

36 天前 - … The coronavirus disease 2019 (COVID-19) pandemic has … of a billion people having
reported COVID-19 cases, many … severe acute respiratory syndrome coronavirus-2 (SARS-…

36 天前 - … immunotherapy potential to govern a variety of infectious diseases. Despite the recent
advances regarding vaccines against COVID-19, … are applied to combat COVID-19. This …

38 天前 - … Despite vaccination, COVID-19 could cause severe disease in cancer pts, also …
first 200 pts treated with chemo-(CT) or immunotherapy. We also evaluated the T-cell immune …

38 天前 - … Results: In both untreated and immunotherapy treated GBM-… in mice treated with
immunotherapy, indicating the effect of … Interestingly, in four post-acute COVID-19 subjects we …

38 天前 - … great application potential in vaccines, immunotherapy, regenerative medicine,
gene editing and so on. In particular, coronavirus disease 2019 (COVID-19) in 2020 has greatly …

40 天前 - … proven clinical value in addressing the COVID-19 pandemic as they combine benefits
of … make them a key tool of vaccinology and immunotherapy going forward. Here, I briefly …